These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10984002)

  • 1. Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review.
    Sporn J; Ghaemi SN; Sambur MR; Rankin MA; Recht J; Sachs GS; Rosenbaum JF; Fava M
    Ann Clin Psychiatry; 2000 Sep; 12(3):137-40. PubMed ID: 10984002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive dopamine agonists in treatment-resistant bipolar II depression: an open case series.
    Perugi G; Toni C; Ruffolo G; Frare F; Akiskal H
    Pharmacopsychiatry; 2001 Jul; 34(4):137-41. PubMed ID: 11518474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression.
    Goldberg JF; Burdick KE; Endick CJ
    Am J Psychiatry; 2004 Mar; 161(3):564-6. PubMed ID: 14992985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of 24-week pramipexole augmentation in patients with treatment resistant depression. A retrospective cohort study.
    Tundo A; Betro' S; Iommi M; de Filippis R
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jan; 112():110425. PubMed ID: 34375683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pramipexole in refractory bipolar depression.
    Goldberg JF; Frye MA; Dunn RT
    Am J Psychiatry; 1999 May; 156(5):798. PubMed ID: 10327923
    [No Abstract]   [Full Text] [Related]  

  • 6. Pramipexole for depression.
    Ostow M
    Am J Psychiatry; 2002 Feb; 159(2):320-1. PubMed ID: 11823287
    [No Abstract]   [Full Text] [Related]  

  • 7. Pramipexole in treatment-resistant depression: a 16-week naturalistic study.
    Lattanzi L; Dell'Osso L; Cassano P; Pini S; Rucci P; Houck PR; Gemignani A; Battistini G; Bassi A; Abelli M; Cassano GB
    Bipolar Disord; 2002 Oct; 4(5):307-14. PubMed ID: 12479663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pramipexole: augmentation in the treatment of depressive symptoms.
    Gupta S; Vincent JL; Frank B
    CNS Spectr; 2006 Mar; 11(3):172-5. PubMed ID: 16575373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pramipexole in treatment-resistant depression: an extended follow-up.
    Cassano P; Lattanzi L; Soldani F; Navari S; Battistini G; Gemignani A; Cassano GB
    Depress Anxiety; 2004; 20(3):131-8. PubMed ID: 15549689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term use of pramipexole in bipolar depression: a naturalistic retrospective chart review.
    El-Mallakh RS; Penagaluri P; Kantamneni A; Gao Y; Roberts RJ
    Psychiatr Q; 2010 Sep; 81(3):207-13. PubMed ID: 20425143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pramipexole in psychiatry: a systematic review of the literature.
    Aiken CB
    J Clin Psychiatry; 2007 Aug; 68(8):1230-6. PubMed ID: 17854248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction.
    Burdick KE; Braga RJ; Nnadi CU; Shaya Y; Stearns WH; Malhotra AK
    J Clin Psychiatry; 2012 Jan; 73(1):103-12. PubMed ID: 22152405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing efficacy/effectiveness and safety/tolerability profiles of adjunctive pramipexole in bipolar depression: acute versus long-term data.
    Dell'Osso B; Ketter TA
    Int Clin Psychopharmacol; 2013 Nov; 28(6):297-304. PubMed ID: 24081199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta-analysis.
    Tundo A; de Filippis R; De Crescenzo F
    Acta Psychiatr Scand; 2019 Aug; 140(2):116-125. PubMed ID: 31111467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of low-dose pramipexole in the treatment of treatment-resistant bipolar depression: a case report].
    Akdeniz F; Aldemir E; Vahip S
    Turk Psikiyatri Derg; 2009; 20(1):94-8. PubMed ID: 19306131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.
    Zarate CA; Payne JL; Singh J; Quiroz JA; Luckenbaugh DA; Denicoff KD; Charney DS; Manji HK
    Biol Psychiatry; 2004 Jul; 56(1):54-60. PubMed ID: 15219473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of pramipexole, a dopamine receptor agonist, as an adjunctive treatment in treatment-resistant depression: an open-label trial.
    Hori H; Kunugi H
    ScientificWorldJournal; 2012; 2012():372474. PubMed ID: 22919308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pramipexole Augmentation for Treatment-Resistant Unipolar and Bipolar Depression in the Real World: A Systematic Review and Meta-Analysis.
    Tundo A; Betro' S; de Filippis R; Marchetti F; Nacca D; Necci R; Iommi M
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ; Myers RR
    Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pramipexole in the management of restless legs syndrome: an extended study.
    Silber MH; Girish M; Izurieta R
    Sleep; 2003 Nov; 26(7):819-21. PubMed ID: 14655914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.